IvWatch

Focus: IvWatch develops medical devices for detecting infiltration in peripheral IV therapy, operating as a specialized biotechnology company in the medical device space. The company focuses on a narrow but clinically important niche within hospital care and infusion management.

Profile data last refreshed 18h ago · AI intelligence enriched 2w ago

Open Jobs

About IvWatch

AI assessmentNot Hiring

No open roles listed right now. Follow IvWatch to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

9 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

ivWatch Model 400

Infiltration of Peripheral IV Therapy

Growth

Primary marketed device with multiple sensor variants (SmartTouch, Milky Way, fiber optic) under active trial validation.

Pipeline & Clinical Trials

Help build intelligence for IvWatch

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused mission in a high-need clinical area with 9 active trials supporting device validation and market expansion
Specialized expertise opportunity in medical device innovation for IV therapy monitoring, a growing hospital safety priority
Small, agile organization structure enables direct impact on product development and commercialization decisions

Watch Out For

Zero active job openings indicates no current hiring and potential organizational stability concerns or limited growth trajectory
Extremely narrow product portfolio with single device variants limits career mobility and cross-functional development opportunities
Complete absence of financial, funding, employee count, and R&D intensity data raises transparency and scale concerns for career planning

Generated by Claude from IvWatch's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

ivWatch Model 400

Infiltration of Peripheral IV Therapy

N/A

Clinical Trials (1)

NCT07228416Milky Way Sensor Motion Validation

N/A

ivWatch Model 400

Infiltration of Peripheral IV Therapy

N/A

Clinical Trials (1)

NCT02553421Optical Detection of Intravenous Infiltration:A Pilot Study

N/A

ivWatch Model 400 with Milky Way Sensor

Infiltration of Peripheral IV Therapy

N/A

Clinical Trials (1)

NCT07311733Milky Way Sensor: Device Validation for Infiltrated Tissues

N/A

Intentional infiltration of a peripheral IV site

Infiltration

N/A

Clinical Trials (1)

NCT01800552Ultrasound Detection of Peripheral IV Infiltration

N/A

Monitoring the Peripheral Intravenous Infusion Site for Infiltration and Extravasation

Infiltration

N/A

Clinical Trials (1)

NCT01476293Monitoring the Peripheral Intravenous Infusion Site for Infiltration and Extravasation

N/A

The ivWatch Model 400

Infiltration of Peripheral IV Therapy

N/A

Clinical Trials (1)

NCT02123745ivWatch Model 400: Device Validation for Infiltrated Tissues

N/A

ivWatch Model 400

Infiltration of Peripheral IV Therapy

N/A

Clinical Trials (1)

NCT02120443ivWatch Model 400: Device Validation for Non-Infiltrated Tissues

N/A

ivWatch Model 400 with SmartTouch Sensor

Infiltration of Peripheral IV Therapy

N/A

Clinical Trials (1)

NCT04064229ivWatch Sensor: Device Validation for Infiltrated Tissues

N/A

ivWatch Model 400 with SmartTouch and fiber optic sensor

Infiltration of Peripheral IV Therapy

N/A

Clinical Trials (1)

NCT04065373ivWatch SmartTouch Sensor: Device Validation for Non-Infiltrated Tissues

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 9 clinical trials

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo